Loading...
Search Filters
Date Range
toReport Types
Condition
See all (5)
Region of the Body
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 11 of 11
Estrogens decrease joint pain, but do not reduce joint swelling, in post-menopausal women
Menopause. 2013 Jun;20(6):600-608
Use of growth hormone therapy for osteoporosis in postmenopausal women: 10 year follow-up
J Clin Endocrinol Metab. 2015 Sep;100(9):3251-9
Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls
Expert Opin Drug Saf. 2018 Apr;17(4):413-428
Eicosapentaenoic and docosahexaenoic acid supplementation in breast cancer patients
Nutr Cancer. 2014;66(1):68-76. doi: 10.1080/01635581.2014.847964. Epub 2013 Nov 25
Zoledronic acid given upfront maintains BMD in postmenopausal breast cancer patients
Cancer. 2012 Mar 1;118(5):1192-201. doi: 10.1002/cncr.26313. Epub 2011 Oct 10
Evaluating raloxifene in postmenopausal Japanese women with osteoporosis or osteopenia
Clin Interv Aging. 2014 Nov 5;9:1879-1893.
The effect of adjuvant aromatase inhibitors on BMD in women with breast cancer
Lancet Oncol. 2014 Apr;15(4):474-82. doi: 10.1016/S1470-2045(14)70035-X. Epub 2014 Mar 11
Olive leaf extract improves osteocalcin level & serum lipid profile in osteopenic women
J Nutr Health Aging. 2015;19(1):77-86
Denosumab reduces secondary fragility fracture risk in osteoporotic women
Climacteric. 2015 Jun 1:1-23
Short-term benefits of tamoxifen in Dupuytren patients with a predisposition to fibrosis
J Bone Joint Surg Am. 2014 Apr 16;96(8):655-62
Showing 1 - 11 of 11